NEW YORK (GenomeWeb News) — French in vitro diagnostics firm BioMérieux said today that it has entered into an agreement to acquire BioFire Diagnostics for $450 million plus BioFire's net financial debt.

BioFire, which until August 2012 was known as Idaho Technology, is based in Salt Lake City, Utah, and markets the FilmArray molecular diagnostics system and associated syndromic infectious disease assay panels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.